Archives
-
Golgi-Tracker Green: Photostable Live-Cell Golgi Imaging Sol
2026-05-23
Golgi-Tracker Green empowers researchers with highly specific, photostable live-cell Golgi apparatus labeling, outperforming conventional probes in clarity and reproducibility. Its BODIPY FL-labeled C5-ceramide foundation enables robust workflows for lipid transport and sphingolipid metabolism analysis.
-
Omeprazole: Technical Guide for H+,K+-ATPase Inhibition
2026-05-22
Omeprazole (SKU A2845) is a potent H+,K+-ATPase inhibitor used in research to study gastric acid secretion and antiulcer mechanisms. This product is best suited for controlled laboratory assays modeling peptic ulcer disease and related gastric acid disorders, but should not be used for diagnostic or medical applications. Researchers must account for its solubility, storage stability, and workflow integration to ensure reproducible results.
-
Enhancing Kidney-Targeted mRNA Nanoparticle Loading via Exci
2026-05-22
This study explores how excipients modulate the mRNA loading capacity of polymeric mesoscale nanoparticles for kidney-targeted delivery. The findings demonstrate that certain excipients improve mRNA encapsulation and stability while maintaining nanoparticle size, offering promising advances for renal gene therapy platforms.
-
EZ Cap™ mCherry mRNA: Precision Red Fluorescent Protein Expr
2026-05-21
Discover how EZ Cap™ mCherry mRNA enables reliable red fluorescent protein expression with enhanced mRNA stability and minimal immune activation. This article bridges advanced assay needs with the latest biosensor and reporter gene innovations.
-
Amyloid Beta-Peptide (1-40) (human): Applied Workflows & Inn
2026-05-21
Amyloid Beta-Peptide (1-40) (human) from APExBIO enables robust, reproducible modeling of amyloid aggregation and neurotoxicity, empowering translational Alzheimer's disease research. Discover advanced workflow enhancements, real-world troubleshooting, and actionable protocol tips grounded in cutting-edge studies.
-
DOT1L Inhibition Primes Immunity, Enhances Lenalidomide Resp
2026-05-20
This study demonstrates that targeting DOT1L, an epigenetic methyltransferase, activates innate immune signaling and amplifies the anti-myeloma efficacy of lenalidomide. The findings suggest that combining DOT1L inhibition with immunomodulatory drugs could address resistance mechanisms and improve multiple myeloma outcomes.
-
Magnetic Nano-Antibodies Enable In Vivo CAR-T-Mimicry for Tu
2026-05-20
This study reports the development of a magnetic bispecific nano-antibody platform (M-BiNanoAb) for in vivo generation and guidance of CAR-T-mimicking cells, overcoming major barriers in solid tumor immunotherapy. The results highlight a new strategy to reprogram circulating T cells and precisely direct their migration into tumors, offering a promising alternative to traditional ex vivo CAR-T cell engineering.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Dual-Reporter mRNA Assays
2026-05-19
Unlock dual fluorescence for real-time mRNA delivery and translation efficiency assays in advanced gene therapy research. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) from APExBIO streamlines quantitative workflows, minimizes innate immune activation, and enables robust functional validation in next-generation nanoparticle optimization.
-
Lipid Nanoparticle Delivery of ABE8e Corrects COL7A1 in DEB
2026-05-19
This study demonstrates the efficient delivery of adenine base editor ABE8e using lipid nanoparticles (LNPs) to correct pathogenic COL7A1 mutations in dystrophic epidermolysis bullosa (DEB) fibroblasts in vitro. These findings highlight a promising gene editing strategy for inherited skin diseases and inform future workflows involving mRNA and protein tracking technologies.
-
EZ Cap™ Cre mRNA (m1Ψ): High-Efficiency Gene Editing Workflo
2026-05-18
EZ Cap™ Cre mRNA (m1Ψ) delivers robust, low-immunogenicity Cre recombinase expression for gene editing and functional studies. Its Cap 1 and m1Ψ modifications support advanced mRNA delivery and streamline in vitro and in vivo protocols—backed by the reliability of APExBIO.
-
Biotin-XX Tyramide Reagent: Precision Cell Surface Labeling
2026-05-18
Biotin-XX Tyramide Reagent empowers highly selective, membrane-impermeant cell surface protein labeling for advanced tyramide signal amplification workflows. Its optimized linker and HRP-catalyzed chemistry deliver unmatched sensitivity in spatial proteomics, as demonstrated by leading-edge proximity labeling techniques.
-
Substance P in Pain Transmission Research: Protocols & Insig
2026-05-17
Unlock the full experimental potential of Substance P—a gold-standard tachykinin neuropeptide—for pain, immune, and neuroinflammation research. This article delivers actionable workflows, troubleshooting strategies, and cross-validated spectral analytics to maximize reproducibility and data clarity in CNS studies.
-
DMH1: A Selective ALK2 Inhibitor for Organoid and NSCLC Rese
2026-05-16
DMH1 stands out as a highly selective ALK2 inhibitor, enabling precise BMP pathway modulation in both organoid engineering and non-small cell lung cancer studies. This article unpacks practical workflows, troubleshooting strategies, and novel applications, translating recent high-impact findings into actionable laboratory protocols.
-
10 mM dNTP Mixture: Precision in DNA Synthesis & Delivery
2026-05-15
The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) mixture enables reliable, high-fidelity DNA synthesis and advanced molecular workflows. Its equimolar formulation ensures reproducibility in PCR, qPCR, and DNA sequencing—crucial for both fundamental research and cutting-edge lipid nanoparticle studies.
-
Firefly Luciferase mRNA: Applied Workflows & Troubleshooting
2026-05-15
EZ Cap™ Firefly Luciferase mRNA (5-moUTP) by APExBIO is engineered for unmatched sensitivity and immune evasion in bioluminescent reporter assays. This article delivers protocol-driven guidance, real-world troubleshooting, and expert insights for maximizing mRNA delivery and translation efficiency in both in vitro and in vivo research.